Comprehensive genomic and molecular profiling for every patient
Scroll down
Precision Medicine, Purpose-Built for LATAM
Precision Medicine, Purpose-Built for LATAM
Our genomic and molecular testing portfolio is designed to help physicians identify specific biological changes , select targeted therapies, and optimize treatment for patients across oncology, rare diseases, cardiology, and neurology. All assays are processed in Biomakers’ ISO-certified laboratories, ensuring accuracy, consistency, and rapid turnaround
Explore our Test Catalog
Filter
All
Oncology
Cardiology, Neurology, and Rare Diseases
Oncology
BRCA 1 & 2 (Germline / Somatic)
Test Description
The BRCA Research Assay is a targeted next-generation sequencing (NGS) panel designed to detect a broad range of variants across BRCA1 and BRCA2, including SNPs, indels, and large indels within the coding regions and select intronic boundaries.
Read More
Optimus Panel
Test Description
The Optimus assay is a targeted NGS panel designed to detect key genomic alterations across clinically relevant solid tumor genes.
Read More
BMK HRR Panel
Test Description
The BMK HRR Panel is a targeted NGS assay designed to detect pathogenic variants across genes in the homologous recombination repair (HRR) pathway.
Read More
BMK HRD Panel
Test Description
The BMK HRD Panel is a comprehensive assay evaluating homologous recombination deficiency (HRD) through targeted sequencing of HRR genes combined with low-pass whole genome sequencing (lpWGS).
Read More
Optimus 500
Test Description
OPTIMUS 500™, is a comprehensive genomic profiling assay targeting 523 genes across DNA and RNA.
Read More
Optimus Liquid
Test Description
OPTIMUS 500 Liquid™, is a comprehensive genomic profiling assay targeting 523 genes across DNA and RNA.
Read More
BMK 500
Test Description
The OCA Plus is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling solution for FFPE solid tumor tissues.
Read More
Cardiology, Neurology, and Rare Diseases
Biomakers offers advanced genetic testing for a wide range of rare inherited conditions using MLPA, PCR-based methods, Sanger sequencing, and next-generation sequencing (NGS).
We support evaluation of neuromuscular, metabolic, cardiac, vascular, and hereditary neuropathic disorders, with customizable gene panels tailored to each patient’s clinical presentation.
Neuromuscular disorders
Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), Friedreich’s Ataxia
Metabolic / systemic disorders
hATTR amyloidosis, porphyrias, familial hypercholesterolemia, primary hyperoxaluria
Cardiovascular & neuropathic disease
Hereditary neuropathies, cardiomyopathies
Cardiac genetic disorders
Hypertrophic cardiomyopathy, Long QT syndrome, inherited cardiomyopathies
Vascular & lymphatic malformations
Congenital vascular malformations, lymphatic malformations
Filter
All
Oncology
Cardiology, Neurology, and Rare Diseases
Oncology
BRCA 1 & 2 (Germline / Somatic)
Test Description
The BRCA Research Assay is a targeted next-generation sequencing (NGS) panel designed to detect a broad range of variants across BRCA1 and BRCA2, including SNPs, indels, and large indels within the coding regions and select intronic boundaries.
Read More
Optimus Panel
Test Description
The Optimus assay is a targeted NGS panel designed to detect key genomic alterations across clinically relevant solid tumor genes.
Read More
BMK HRR Panel
Test Description
The BMK HRR Panel is a targeted NGS assay designed to detect pathogenic variants across genes in the homologous recombination repair (HRR) pathway.
Read More
BMK HRD Panel
Test Description
The BMK HRD Panel is a comprehensive assay evaluating homologous recombination deficiency (HRD) through targeted sequencing of HRR genes combined with low-pass whole genome sequencing (lpWGS).
Read More
Optimus 500
Test Description
OPTIMUS 500™, is a comprehensive genomic profiling assay targeting 523 genes across DNA and RNA.
Read More
Optimus Liquid
Test Description
OPTIMUS 500 Liquid™, is a comprehensive genomic profiling assay targeting 523 genes across DNA and RNA.
Read More
BMK 500
Test Description
The OCA Plus is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling solution for FFPE solid tumor tissues.
Read More
Cardiology, Neurology, and Rare Diseases
Biomakers offers advanced genetic testing for a wide range of rare inherited conditions using MLPA, PCR-based methods, Sanger sequencing, and next-generation sequencing (NGS).
We support evaluation of neuromuscular, metabolic, cardiac, vascular, and hereditary neuropathic disorders, with customizable gene panels tailored to each patient’s clinical presentation.
Neuromuscular disorders
Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), Friedreich’s Ataxia
Metabolic / systemic disorders
hATTR amyloidosis, porphyrias, familial hypercholesterolemia, primary
hyperoxaluria
Cardiovascular & neuropathic disease
Hereditary neuropathies,
cardiomyopathies
Cardiac genetic disorders
Hypertrophic cardiomyopathy, Long QT syndrome, inherited cardiomyopathies
Vascular & lymphatic malformations
Congenital vascular malformations, lymphatic malformations
Filter
All
Oncology
Cardiology, Neurology, and Rare Diseases
Oncology
BRCA 1 & 2 (Germline / Somatic)
Test Description
The BRCA Research Assay is a targeted next-generation sequencing (NGS) panel designed to detect a broad range of variants across BRCA1 and BRCA2, including SNPs, indels, and large indels within the coding regions and select intronic boundaries.
Read More
Optimus Panel
Test Description
The Optimus assay is a targeted NGS panel designed to detect key genomic alterations across clinically relevant solid tumor genes.
Read More
BMK HRR Panel
Test Description
The BMK HRR Panel is a targeted NGS assay designed to detect pathogenic variants across genes in the homologous recombination repair (HRR) pathway.
Read More
BMK HRD Panel
Test Description
The BMK HRD Panel is a comprehensive assay evaluating homologous recombination deficiency (HRD) through targeted sequencing of HRR genes combined with low-pass whole genome sequencing (lpWGS).
Read More
Optimus 500
Test Description
OPTIMUS 500™, is a comprehensive genomic profiling assay targeting 523 genes across DNA and RNA.
Read More
Optimus Liquid
Test Description
OPTIMUS 500 Liquid™, is a comprehensive genomic profiling assay targeting 523 genes across DNA and RNA.
Read More
BMK 500
Test Description
The OCA Plus is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling solution for FFPE solid tumor tissues.
Read More
Cardiology, Neurology, and Rare Diseases
Biomakers offers advanced genetic testing for a wide range of rare inherited conditions using MLPA, PCR-based methods, Sanger sequencing, and next-generation sequencing (NGS).
We support evaluation of neuromuscular, metabolic, cardiac, vascular, and hereditary neuropathic disorders, with customizable gene panels tailored to each patient’s clinical presentation.
Neuromuscular disorders
Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), Friedreich’s Ataxia
Metabolic / systemic disorders
hATTR amyloidosis, porphyrias, familial hypercholesterolemia,
primary hyperoxaluria
Cardiovascular & neuropathic disease
Hereditary neuropathies, cardiomyopathies
Cardiac genetic disorders
Hypertrophic cardiomyopathy, Long QT syndrome, inherited cardiomyopathies
Vascular & lymphatic malformations
Congenital vascular malformations, lymphatic malformations
Quality & Certifications
ISO 9001:2015–certified laboratories with external validation from:
ISO 9001:2015–certified laboratories with external validation from:
Ensuring
Reliable
Reliable
Meaningful
Actionable
results.